377,875 Shares in Astera Labs, Inc. $ALAB Bought by Mirae Asset Global Investments Co. Ltd.

Mirae Asset Global Investments Co. Ltd. bought a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 377,875 shares of the company’s stock, valued at approximately $134,512,000. Mirae Asset Global Investments Co. Ltd. owned 0.22% of Astera Labs as of its most recent SEC filing.

Several other large investors also recently modified their holdings of the stock. Keating Financial Advisory Services Inc. purchased a new stake in Astera Labs in the second quarter worth $25,000. GK Wealth Management LLC purchased a new position in shares of Astera Labs during the 3rd quarter valued at $29,000. Archer Investment Corp purchased a new position in shares of Astera Labs during the 2nd quarter valued at $30,000. Whipplewood Advisors LLC grew its stake in shares of Astera Labs by 15,950.0% during the 1st quarter. Whipplewood Advisors LLC now owns 321 shares of the company’s stock worth $35,000 after acquiring an additional 319 shares during the period. Finally, Transamerica Financial Advisors LLC bought a new position in shares of Astera Labs during the 2nd quarter worth $35,000. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Insider Transactions at Astera Labs

In other news, Director Stefan Dyckerhoff sold 8,994 shares of the firm’s stock in a transaction that occurred on Wednesday, October 7th. The shares were sold at an average price of $376.06, for a total value of $3,382,283.64. Following the completion of the transaction, the director directly owned 2,648 shares in the company, valued at approximately $995,806.88. This trade represents a 77.25% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 6,801 shares of the firm’s stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $340.50, for a total transaction of $2,315,740.50. Following the completion of the transaction, the general counsel owned 96,542 shares of the company’s stock, valued at $32,872,551. This trade represents a 6.58% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last 90 days, insiders sold 408,558 shares of company stock valued at $127,306,034. Company insiders own 10.40% of the company’s stock.

Astera Labs Stock Performance

Shares of NASDAQ ALAB opened at $258.70 on Friday. The stock has a market cap of $44.88 billion, a PE ratio of 128.07 and a beta of 3.68. Astera Labs, Inc. has a fifty-two week low of $97.89 and a fifty-two week high of $499.48. The stock has a fifty day moving average of $308.12 and a 200-day moving average of $254.98.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. The business had revenue of $392.40 million for the quarter, compared to analysts’ expectations of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%. The firm’s quarterly revenue was up 104.5% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, sell-side analysts predict that Astera Labs, Inc. will post 2.71 EPS for the current year.

Wall Street Analyst Weigh In

ALAB has been the subject of several recent research reports. Royal Bank Of Canada lifted their price objective on Astera Labs from $425.00 to $500.00 and gave the stock an “outperform” rating in a report on Wednesday, August 5th. Citigroup downgraded shares of Astera Labs from a “buy” rating to a “hold” rating in a report on Friday, October 9th. Weiss Ratings downgraded shares of Astera Labs from a “buy (b-)” rating to a “hold (c)” rating in a research note on Friday, October 23rd. TD Cowen lowered their price target on shares of Astera Labs from $375.00 to $300.00 and set a “hold” rating on the stock in a research report on Monday, October 19th. Finally, UBS Group restated a “neutral” rating and set a $425.00 price target on shares of Astera Labs in a research note on Wednesday, August 5th. Eleven analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $340.79.

About Astera Labs

Astera Labs, Inc is a semiconductor and connectivity solutions company that develops hardware and software for data centers, cloud computing, and artificial intelligence infrastructure. Its products are designed to help move data between processors, memory, storage, and networking components while addressing bandwidth, latency, and system-management requirements.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) Smart Retimers, Taurus Ethernet Smart Cable Modules, Scorpio Smart Fabric Switches, and Leo CXL Memory Connectivity Controllers.